GoodRx Holdings, Inc.GDRXNASDAQ
Loading
Cash Flow PerformanceStable
Percentile Rank71
3Y CAGR+5.8%
5Y CAGR+2.6%
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

3Y CAGR
+5.8%/yr
vs +21.7%/yr prior
5Y CAGR
+2.6%/yr
Recent acceleration
Acceleration
-15.9pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive declineStable
PeriodValueYoY Change
TTM$108.47M-4.5%
2024$113.55M+37.6%
2023$82.53M-9.9%
2022$91.57M-36.6%
2021$144.32M+51.1%
2020$95.52M+23.2%
2019$77.54M+85.5%
2018$41.80M-